LT3481437T - Radiofluorinimo pirmtakai - Google Patents

Radiofluorinimo pirmtakai

Info

Publication number
LT3481437T
LT3481437T LTEPPCT/DE2017/100986T LTDE2017100986T LT3481437T LT 3481437 T LT3481437 T LT 3481437T LT DE2017100986 T LTDE2017100986 T LT DE2017100986T LT 3481437 T LT3481437 T LT 3481437T
Authority
LT
Lithuania
Prior art keywords
radiofluorination
precursors
Prior art date
Application number
LTEPPCT/DE2017/100986T
Other languages
English (en)
Inventor
René Martin
René SMITS
Ronny Hesse
Alexander Hoepping
Marco Müller
Sandra HÜBNER
Original Assignee
Abx Advanced Biochemical Compounds Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abx Advanced Biochemical Compounds Gmbh filed Critical Abx Advanced Biochemical Compounds Gmbh
Publication of LT3481437T publication Critical patent/LT3481437T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
LTEPPCT/DE2017/100986T 2016-11-18 2017-11-17 Radiofluorinimo pirmtakai LT3481437T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102016122273.9A DE102016122273B4 (de) 2016-11-18 2016-11-18 Präkursoren für die Radiofluorierung
PCT/DE2017/100986 WO2018091043A1 (de) 2016-11-18 2017-11-17 Präkursoren für die radiofluorierung

Publications (1)

Publication Number Publication Date
LT3481437T true LT3481437T (lt) 2022-05-10

Family

ID=60627367

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/DE2017/100986T LT3481437T (lt) 2016-11-18 2017-11-17 Radiofluorinimo pirmtakai

Country Status (15)

Country Link
US (2) US10759760B2 (lt)
EP (1) EP3481437B1 (lt)
JP (2) JP2019535727A (lt)
KR (1) KR102233598B1 (lt)
CN (2) CN109982722B (lt)
AU (1) AU2017359864B2 (lt)
BR (1) BR112019022760A2 (lt)
CA (1) CA3044102C (lt)
DE (1) DE102016122273B4 (lt)
DK (1) DK3481437T3 (lt)
ES (1) ES2911753T3 (lt)
HU (1) HUE058846T2 (lt)
IL (1) IL266683B2 (lt)
LT (1) LT3481437T (lt)
WO (1) WO2018091043A1 (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016122273B4 (de) * 2016-11-18 2018-06-21 Abx Advanced Biochemical Compounds Gmbh Präkursoren für die Radiofluorierung
WO2018098390A1 (en) * 2016-11-23 2018-05-31 Cancer Targeted Technology Llc Albumin-binding psma inhibitors
CN111253465A (zh) * 2020-03-03 2020-06-09 复旦大学附属肿瘤医院 一种psma结合剂及其用途
CN111548305B (zh) * 2020-05-12 2021-08-31 北京师范大学 一种可用于靶向psma的喹啉类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009035959A2 (en) * 2007-09-10 2009-03-19 Ge Healthcare Limited Radiofluorination methods
CN107382846B (zh) * 2008-08-01 2021-07-06 约翰.霍普金斯大学 Psma-结合剂及其用途
WO2011006610A1 (en) * 2009-07-11 2011-01-20 Bayer Schering Pharma Aktiengesellschaft Non-polar and polar leaving groups
WO2015004029A1 (en) 2013-07-08 2015-01-15 Technische Universität München 18f-labeling of aromatic and heteroaromatic molecules with unprotected carboxylic acid groups
CN103595631B (zh) 2013-10-31 2016-12-07 华为技术有限公司 一种路径建立的方法和装置
EP2993171A1 (en) * 2014-09-04 2016-03-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the production of 18F-labeled PSMA-specific PET-tracers
ES2912753T3 (es) * 2014-08-24 2022-05-27 Max Planck Gesellschaft Zur Foerderung Der Wss Método para la producción de ésteres activos marcados con 18F y su aplicación ejemplificada por la preparación de un marcador de PET específico de PSMA
US10736974B2 (en) * 2014-10-22 2020-08-11 The Johns Hopkins University Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
US11078166B2 (en) * 2015-08-13 2021-08-03 The Johns Hopkins University Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof
US20180236109A1 (en) * 2015-08-20 2018-08-23 Universitat Zu Koln Pain Tracking by PET-imaging (Pain-TraP)
EA037512B1 (ru) 2015-09-30 2021-04-06 Дойчес Кребсфоршунгсцентрум Улучшенные ингибиторы простатического специфического мембранного антигена (псма), меченные 18f, и их применение в качестве визуализирующих агентов при раке простаты
US20200231614A1 (en) * 2015-10-22 2020-07-23 The Johns Hopkins University Psma targeted radiohalogenated ureas for cancer radiotherapy
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method
US10882871B2 (en) * 2016-01-10 2021-01-05 British Columbia Cancer Agency Branch 18/19F-labelled compounds which target the prostate specific membrane antigen
EP3481804A4 (en) * 2016-06-10 2019-11-13 The Johns Hopkins University IMPROVED SYNTHESIS OF RADIOACTIVELY MARKED PROSTATE-SPECIFIC MEMBRANE-ANTIBODY (PSMA) INHIBITOR [18F] DCFPYL
SG10202013129YA (en) * 2016-06-28 2021-01-28 Univ Cornell 18f-labeled triazole containing psma inhibitors
DE102016122273B4 (de) * 2016-11-18 2018-06-21 Abx Advanced Biochemical Compounds Gmbh Präkursoren für die Radiofluorierung

Also Published As

Publication number Publication date
IL266683B2 (en) 2023-09-01
JP2019535727A (ja) 2019-12-12
CA3044102A1 (en) 2018-05-24
IL266683B1 (en) 2023-05-01
US10759760B2 (en) 2020-09-01
EP3481437B1 (de) 2022-01-26
DK3481437T3 (en) 2022-04-25
IL266683A (en) 2019-07-31
US20190263756A1 (en) 2019-08-29
EP3481437A1 (de) 2019-05-15
CA3044102C (en) 2021-08-10
ES2911753T3 (es) 2022-05-20
US20200165204A1 (en) 2020-05-28
BR112019022760A2 (pt) 2020-05-12
CN109982722B (zh) 2024-03-08
DE102016122273B4 (de) 2018-06-21
DE102016122273A1 (de) 2018-05-24
CN115650813B (zh) 2024-07-19
HUE058846T2 (hu) 2022-09-28
JP7261269B2 (ja) 2023-04-19
AU2017359864B2 (en) 2020-10-22
JP2021176909A (ja) 2021-11-11
CN115650813A (zh) 2023-01-31
CN109982722A (zh) 2019-07-05
KR20190070945A (ko) 2019-06-21
WO2018091043A1 (de) 2018-05-24
US11053200B2 (en) 2021-07-06
AU2017359864A1 (en) 2019-05-16
KR102233598B1 (ko) 2021-03-30

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
IL286839A (en) Propyne-indole compounds
GB201602934D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201610854D0 (en) Compounds
PL3464336T3 (pl) Związki
GB201620119D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201608777D0 (en) Compounds
IL266683A (en) Precursors for radiofluorination reactions
IL263228A (en) Benzoxaborole compounds
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201720511D0 (en) Compounds
GB201622083D0 (en) Compounds